Full Press Release Details
Data Published In Nature Communications Demonstrates CoA Therapeutics' Potential To Treat Genetically Driven Pantothenate Kinase-associated Neurodegeneration (PKAN).
BBIO
Data Published In Nature Communications Demonstrates CoA Therapeutics' Potential To Treat Genetically Driven Pantothenate Kinase-associated Neurodegeneration (PKAN)
Key Takeaway: Data Published In Nature Communications Demonstrates CoA Therapeutics' Potential To Treat Genetically Driven Pantothenate Kinase-associated Neurodegeneration (PKAN)